About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

PeptiDream Inc.(4587) Summary

4587
TSE Prime
PeptiDream Inc.
2,443.0
JPY
-27.0
(-1.09%)
Jan 9, 1:49 pm JST
15.46
USD
Jan 8, 11:49 pm EST
Result
PTS
outside of trading hours
2,441
Jan 9, 1:42 pm JST
Summary Chart Historical News Financial Result
PER
22.6
PBR
5.42
Yield
ー%
Margin Trading Ratio
8.94
Stock Price
Jan 9, 2025
Opening Jan 9, 9:00 am
2,440.0 JPY 15.42 USD
Previous Close Jan 8
2,470.0 JPY 15.62 USD
High Jan 9, 11:18 am
2,461.0 JPY 15.57 USD
Low Jan 9, 9:01 am
2,422.0 JPY 15.31 USD
Volume
392,900
Trading Value
0.96B JPY 6.07M USD
VWAP
2439.05 JPY 15.44 USD
Minimum Trading Value
244,300 JPY 1,546 USD
Market Cap
0.32T JPY 2.02B USD
Number of Trades
1,761
Liquidity & Number of Trades
As of Jan 9, 2025
Liquidity
High
1-Year Average
3,226
1-Year High Nov 14, 2024
13,116
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 27, 2024 72,900 1,206,700 16.55
Dec 20, 2024 85,400 1,212,300 14.20
Dec 13, 2024 98,100 1,118,900 11.41
Dec 6, 2024 134,900 1,019,600 7.56
Nov 29, 2024 181,700 992,900 5.46
Company Profile
PeptiDream Inc. is a drug discovery venture company that collaborates with major pharmaceutical companies to develop peptide-based drugs. The company has also acquired a radiopharmaceutical business.
Sector
Pharmaceuticals
PeptiDream Inc. is a biotech venture originating from the University of Tokyo, focusing primarily on drug discovery and development using special peptides through its proprietary drug discovery platform system, PDPS. The company engages in collaborative drug research and development using PDPS, technology licensing, and strategic partnerships to expand its in-house pipeline. Through its subsidiary PDR Pharma, PeptiDream Inc. also operates in the radiopharmaceutical business, conducting research, development, manufacturing, and sales of diagnostic and therapeutic radiopharmaceuticals. The company concentrates on developing diagnostic agents for imaging cancer and abnormal brain accumulations, as well as therapeutic radiopharmaceuticals targeting unmet medical needs, particularly in the field of oncology. As a group, PeptiDream Inc. operates across a wide range of areas including research, development, manufacturing, and sales of pharmaceuticals and related products.